Skip to content
Bamboo Works
Search
Register / Sign in
MSCI China | MSCI China Small-Cap | Hang Seng Index | Hang Seng China Enterprise
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Audio/Video
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us
  • Eng
  • 简中
  • 繁中
Menu
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Audio/Video
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us

Cardiovascular and oncology

Founded in 2001 and listed in Hong Kong in 2010, Sihuan originally specialized in the production of cardiovascular and oncology generic drugs, and is one of the largest cardiovascular prescription drug suppliers in China.

FAST NEWS: Sihuan Pharma stock skyrockets on latest share buyback program

The Latest: Sihuan Pharmaceutical Holdings Group Ltd. (0460.HK) on Sunday announced a new program to purchase up to HK$500 million ($64 million) worth of its shares on the open market over the next…
October 7, 2024
0460.HK

Recent Articles

Founded in 2001 and listed in Hong Kong in 2010, Sihuan originally specialized in the production of cardiovascular and oncology generic drugs, and is one of the largest cardiovascular prescription drug suppliers in China.
October 7, 2024

FAST NEWS: Sihuan Pharma stock skyrockets on latest share buyback program

0460.HK

RELATED ARTICLES

  1. Earnings blow for CSPC Pharma
    March 6, 2025
    Earnings blow for CSPC Pharma as the state drives a hard bargain
    1093.HK
  2. February 27, 2025
    Airdoc Tech enjoys healing properties of medical AI rally
    2251.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

China stock insights and analysis for global investors: Bamboo Works unlocks investment opportunities in Chinese companies listed in the U.S. & Hong Kong.

  • About Us
  • Fast News
  • Audio/Video
  • Expert Corner
  • China ESG
Facebook Twitter Linkedin Weixin Weibo Youtube

Categories

  • New Energy
  • IPO
  • AI/Infrastructure/Resources
  • Education
  • Finance
  • Social Media/Entertainment
  • Consumer
  • Ecommerce
  • Healthcare/biotech
  • Property

Newsletter

Discover hidden China stock gems in our weekly newsletter
Copyright © 2021 - 2025 Bamboo Works. All rights reserved.